Xeris Pharmaceuticals | Crediti Commerciali



Trade Debtors Cambiamento Data
Adcock Ingram Holdings ZAR 2.31B 53.49M 2024-12
Celltrion KRW 1.28T 205.45B 2025-03
Cspc Pharmaceutical CNY 9.62B 2.01B 2024-12
Dianthus Therapeutics USD 807K 1.88M 2024-12
Divis Laboratories Ltd 27.44B 5.42B 2025-03
Eli Lilly USD 17.21B 3.2B 2025-06
Kangmei Pharma CNY 3.17B 40.28M 2025-03
Knight Therapeutics CAD 103M 8.1M 2024-09
Laboratorios Farma EUR 134.77M 8.54M 2024-06
Malin Corporation EUR 500K 300K 2024-12
Medical Developments International AUD 7.81M 743K 2024-12
Neuren Pharmaceuticals AUD 175.72M 160.85M 2024-12
Organigram Holdings CAD 47.09M 9.94M 2024-12
Pacira USD 114.37M 9.62M 2025-06
Perrigo USD 678.2M 38.6M 2025-06
Pharma Mar EUR 67.87M 24.58M 2025-06
Qiagen NV USD 385.76M 45.05M 2025-06
Sartorius EUR 393.2M 14.3M 2025-06
Sino Biopharmaceutical CNY 5.26B 2.1B 2024-12
Supernus Pharmaceuticals USD 140.83M 4.81M 2025-06
Tilray USD 112.74M 8.7M 2024-11
Zz Pientze Pharmaceu 1.07B 15.81M 2025-03


Xeris Pharmaceuticals Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.